318160 — Cell Bio Human Tech Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsSpeculativeMicro CapNeutral

Market Cap
KR₩61bn
Enterprise Value
KR₩68bn
Revenue
KR₩51bn

Annual balance sheet for Cell Bio Human Tech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	21,385	6,895	13,485	14,306	16,601
Net Total Accounts Receivable
Net Total Receivables	3,766	3,104	4,337	4,056	10,965
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	32,071	19,936	26,918	23,992	44,021
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	23,904	23,152	22,764	24,568	35,493
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	58,069	45,982	53,196	52,905	88,458
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19,477	13,706	8,559	6,284	19,197
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	29,202	13,835	8,634	6,493	31,715
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	28,867	32,147	44,563	46,412	56,742
Total Liabilities & Shareholders' Equity	58,069	45,982	53,196	52,905	88,458
Total Common Shares Outstanding
Total Preferred Shares Outstanding